PubRank

Andrew M Wilson

Author PubWeight™ 46.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial. Thorax 2012 3.01
2 The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol 2013 2.41
3 A probabilistic characterization of the relationship between fine particulate matter and mortality: elicitation of European experts. Environ Sci Technol 2007 1.57
4 Quantifying the efficiency and equity implications of power plant air pollution control strategies in the United States. Environ Health Perspect 2007 1.42
5 Estimation of primary and secondary particulate matter intake fractions for power plants in Georgia. Environ Sci Technol 2003 1.42
6 High incidence of insulin resistance and dysglycemia amongst nondiabetic cardiac surgical patients. Ann Thorac Surg 2012 1.41
7 Combined proximal endografting with distal bare-metal stenting for management of aortic dissection. Ann Thorac Surg 2011 1.41
8 Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function. Nephrol Dial Transplant 2005 1.28
9 The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects. Atherosclerosis 2008 1.23
10 Intravenous leiomyomatosis with intracardiac extension - a review of diagnosis and management with an illustrative case. Surg Oncol 2013 1.21
11 Barriers to pulmonary rehabilitation: characteristics that predict patient attendance and adherence. Respir Med 2012 1.20
12 Factors influencing mobile source particulate matter emissions-to-exposure relationships in the Boston urban area. Environ Sci Technol 2007 1.16
13 Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease. Diabetes Care 2005 1.14
14 Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies: a statistical analysis. Am J Clin Pathol 2011 1.05
15 A biomarker panel for peripheral arterial disease. Vasc Med 2008 1.01
16 A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph Lateral Scler 2010 1.00
17 Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study. Cardiovasc Diabetol 2011 0.98
18 Biomarkers of peripheral arterial disease. J Am Coll Cardiol 2010 0.98
19 Improvement in timing and effectiveness of external cardiac compressions with a new non-invasive device: the CPR-Ezy. Resuscitation 2002 0.94
20 The at-risk registers in severe asthma (ARRISA) study: a cluster-randomised controlled trial examining effectiveness and costs in primary care. Thorax 2012 0.93
21 Oral montelukast in acute asthma exacerbations: a randomised, double-blind, placebo-controlled trial. Thorax 2010 0.91
22 Screening for IgG antinuclear autoantibodies by HEp-2 indirect fluorescent antibody assays and the need for standardization. Am J Clin Pathol 2012 0.87
23 Therapeutic ratio of hydrofluoroalkane and chlorofluorocarbon formulations of fluticasone propionate. Chest 2002 0.86
24 Vitamin D and COPD: seasonal variation is important. Thorax 2010 0.86
25 Meta-review: adverse effects of inhaled corticosteroids relevant to older patients. Drugs 2014 0.85
26 Myopathy and possible intestinal dysfunction in a patient treated with colchicine and simvastatin. Med J Aust 2012 0.84
27 Myocardial production and release of MCP-1 and SDF-1 following myocardial infarction: differences between mice and man. J Transl Med 2011 0.84
28 Does diabetes mellitus alter the onset and clinical course of vascular dementia? Behav Neurol 2010 0.81
29 Intermittent hypoxia conditioning prevents behavioral deficit and brain oxidative stress in ethanol-withdrawn rats. J Appl Physiol (1985) 2008 0.81
30 Oral delivery of a probiotic induced changes at the nasal mucosa of seasonal allergic rhinitis subjects after local allergen challenge: a randomised clinical trial. PLoS One 2013 0.80
31 A nonfeminizing estrogen analog protects against ethanol withdrawal toxicity in immortalized hippocampal cells. J Pharmacol Exp Ther 2006 0.80
32 When collateral supply is accounted for epicardial stenosis does not increase microvascular resistance. Circ Cardiovasc Interv 2012 0.79
33 Ethanol withdrawal provokes opening of the mitochondrial membrane permeability transition pore in an estrogen-preventable manner. J Pharmacol Exp Ther 2008 0.79
34 Single and short-term dosing effects of levocetirizine on adenosine monophosphate bronchoprovocation in atopic asthma. Br J Clin Pharmacol 2004 0.79
35 Short-term repeatability and correlates of laboratory measures of nasal function in patients with seasonal allergic rhinitis. Rhinology 2002 0.78
36 Impact of right atrial pressure on decision-making using fractional flow reserve (FFR) in elective percutaneous intervention. Int J Cardiol 2012 0.78
37 Managing chronic rhinosinusitis and respiratory disease: a qualitative study of triggers and interactions. J Asthma 2015 0.78
38 5-Lipoxygenase polymorphism and in-vivo response to leukotriene receptor antagonists. Eur J Clin Pharmacol 2002 0.78
39 Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: an economic evaluation alongside a randomised controlled trial. Pharmacoeconomics 2014 0.77
40 The effect of angiotensin-converting enzyme inhibitors and statins on the progression of aortic sclerosis and mortality. J Heart Valve Dis 2012 0.76
41 Recurrent spontaneous coronary artery dissection with transient left ventricular systolic dysfunction. Int J Cardiol 2006 0.76
42 Effects of dual therapy with corticosteroids plus long acting beta2-agonists in asthma. Respir Med 2005 0.76
43 Biomarkers in adult asthma: a systematic review of 8-isoprostane in exhaled breath condensate. J Breath Res 2017 0.76
44 Author's response: co-trimoxazole treatment in idiopathic pulmonary fibrosis. Thorax 2013 0.75
45 Are vascular function measurements ready for the clinic? Eur Heart J 2005 0.75
46 Asthma at-risk registers--can be effective if carefully constructed and correctly implemented. Prim Care Respir J 2012 0.75
47 Thioflavin T fluorescence in human serum: correlations with vascular health and cardiovascular risk factors. Clin Biochem 2009 0.75
48 Alteplase beyond three hours in ischemic stroke: do we know enough? Int J Stroke 2009 0.75
49 Airways resistance in bronchial challenge testing. J Asthma 2014 0.75
50 Latent plaque rupture in a patient undergoing stenting for acute coronary syndrome and diffuse coronary disease: a case report and review of literature. Catheter Cardiovasc Interv 2006 0.75